Clot Retrievers segment to dominate the Global Neurothrombectomy Devices Market till 2026
Changing lifestyle and
increasing old age population is expected to drive the demand for global neurothrombectomy
devices market in the forecast period.
According to TechSci Research report, “Global Neurothrombectomy
Devices Market By Product (Clot Retrievers, Aspiration Devices, Vascular
Snares, Others) By End-User (Hospitals, Ambulatory Surgical Centers, Others),
By Region, Company Forecast & Opportunities, 2026”, The global neurothrombectomy
devices market is expected to witness steady growth for the upcoming five
years. Use of neurothrombectomy devices are used to reduce the effect of acute
ischemic stroke which is one of the most common strokes happening around the
world and reduces the supply of oxygen into the brain thereby destroy the affected
brain cells. Neurobectomy devices are used to destroy or reduce the number of
blood clots in cerebral neurovasculature. These devices lower the mortality
rate of patients and improves the functional outcomes of patients which is the
main reason neurothrombectomy devices are preferred to cure the acute ischemic
stroke. Neurothrombectomy devices allow patients to reduce or avoid the use of
pharmacologic thrombolysis which is expected to minimize the risk of
intracerebral hemorrhage. These devices are used for short duration to which
rtPA is limited. Neurothrombectomy devices provide more rapid recanalization
than thrombolytics. Launch of initiatives by government authorities to raise
the awareness about healthy lifestyle and its effect on the cardiovascular
system is leading to minimize the occurrence of strokes from such individuals.
The COVID-19 outbreak across the world which has been
declared as pandemic by World Health Organization has affected countries
adversely. Leading authorities around the world imposed lockdown restrictions
and released a set of precautionary measures to contain the spread of novel
coronavirus. Coronavirus affected patients started suffering from shortness of
breath along with coughing and sneezing. Leading authorities increased the
capacity of hospitals as a greater number of patients were getting affected
daily and getting admitted into the hospital facilities. Disruption in the
supply chain and delay in the progress of clinical trials is leading to the
delay in launch of new therapies which is expected to hamper the growth of the
neurothrombectomy devices market.
Browse XX Figures spread
through XX Pages and an in-depth TOC on "Global Neurothrombectomy Devices
Market”.
https://www.techsciresearch.com/report/neurothrombectomy-devices-market/7590.html
Global
neurothrombectomy devices market is segmented into product, end-user, regional
distribution, and company. Based on product, market can be further divided into
clot retrievers, aspiration devices, vascular snares, and others. The clot
retriever segment is expected to account for major market share for the
forecast period, 2022-2026. Increasing occurrence of targeted diseases and its
adverse effects is expected to boost the demand for neurothrombectomy devices
market. Clot retriever is used to remove blood clot from cerebral arteries.
Increasing number of product launches and occurrence of acute ischemic stroke
are another factor contributing to the growth of the neurothrombectomy devices.
Based on end-user, market can be fragmented into hospitals, ambulatory surgical
centers, among others. The hospitals segment is expected to account for largest
revenue throughout the forecast period. Availability of advanced equipment and
latest technology in hospital facilities along with the presence of skilled
healthcare professionals is contributing to high demand for neurothrombectomy
devices. Huge patient in-flow into the hospital facilities and increasing
number of hospitals are attracting a huge crowd towards it. Supportive
government policies and insurance coverage for availing healthcare services are
accelerating the market growth.
Abbott Laboratories Inc., Medtronic
Plc., Stryker Corporation, Acandis GmbH, Phenox GmbH, Penumbra Inc., Vesalio,
LLC, Siemens Healthineers AG, Inari Medical Inc., Johnson & Johnson are the
leading players operating in global neurothrombectomy devices market. Manufacturers
are increasingly focusing on research and development process to fuel higher
growth in the market. To meet evolving customer demand with respect to better
efficiency and durability, several neurothrombectomy devices manufacturers are
coming up with their technologically advanced offerings.
Download
Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7590
Customers can also
request for 10% free customization on this report.
“Market
players are investing huge amounts for research and development activities to
introduce technologically advanced neurothrombectomy products and quick
approval procedures for neurothrombectomy devices is expected to boost the
demand of devices. Advanced neurothrombectomy devices are coming up with
optimized delivery system, distal filters which is expected to accelerate the
growth of neurothrombectomy devices. Also, the manufacturing of less invasive
devices to facilitate ease and convenience to patients along with high
healthcare expenditure is expected to propel the growth of the
neurothrombectomy devices market till 2026” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based global management consulting firm.
“Global
Neurothrombectomy Devices Market By Product (Clot Retrievers, Aspiration
Devices, Vascular Snares, Others) By End-User (Hospitals, Ambulatory Surgical
Centers, Others) , By Region, Company Forecast & Opportunities, 2026” has
evaluated the future growth potential of global neurothrombectomy devices
market and provided statistics & information on market size, shares, structure
and future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in the of global neurothrombectomy
devices market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website : https://www.techsciresearch.com/